Risk Stratification of Heart Failure in Cardiomyopathies.

• Status: Recruiting
• Trial end date: 2021-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The investigators aimed to use CMR technique in helping diagnose the etiology of unknown cardiomyopathy. Try to make a risk stratification of susceptible heart failure based on the extent of myocardial impairment.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: RenJi Hospital
• Treatments: Adrenergic beta-Antagonists; Captopril; Furosemide; Spironolactone

Criteria

Inclusion Criteria:

• Participants with cardiomyopathy diagnosed by medical history, clinical symptoms, laboratory tests including ECG, echocardiography.

• no known etiology of cardiomyopathy was confirmed.

Exclusion Criteria:

• with contraindications of magnetic resonance include: 1, participants with cardiac pacemakers and nerve stimulator; 2, participants who have done aneurysm surgery and intracranial with aneurysm folder; 3, participants with the metal foreign body in the eye; 4, pregnant women; 5, critically ill participants need life support systems; 6, epilepsy participants; 7, claustrophobic participants;.

• participants who are <15 years of age or >75 years.

• participants who have the contraindication use of contrast media: glomerular filtration rate <30 ml/min